Intravitreal bevacizumab versus photodynamic therapy for myopic choroidal neovascularization in a North-African population

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 249, Issue 9, 2011, Pages 1287-1293

  El Matri, Leila ^a   Kort, Fedra ^a   Chebil, Ahmed ^a   Bouraoui, Rim ^a   Merdassi, Ahlem ^a   Bouladi, Mejda ^a  

^a Institut Hedi Rais d'Ophtalmologie   (Tunisia)

Author keywords

Choroidal neovascularization; Intravitreal bevacizumab; Myopia; Photodynamic therapy

Indexed keywords

BEVACIZUMAB;

ADULT; ARTICLE; CENTRAL RETINAL THICKNESS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OFF LABEL DRUG USE; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL SYSTEM PARAMETERS;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; CHOROIDAL NEOVASCULARIZATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; MALE; MIDDLE AGED; MYOPIA, DEGENERATIVE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETREATMENT; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; TUNISIA;

EID: 80052714032     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-011-1654-4     Document Type: Article

References (26)

1. SY Cohen A Laroche Y Leguen G Soubrane GJ Coscas 1996 Etiology of choroidal neovascularization in young patients Ophthalmology 103 1241 1244 8764794 1:STN:280:DyaK28zltVartw%3D%3D (Pubitemid 26282507)
2. T Yoshida K Ohno-Matsui K Yasuzumi A Kojima N Shimada S Futagami T Tokoro M Mochizuki 2003 Myopic choroidal neovascularisation: a 10-year follow-up Ophthalmology 110 1297 1305 12867382 10.1016/S0161-6420(03)00461-5 (Pubitemid 36842462)
3. Verteporfin in Photodynamic Therapy Study Group 2001 Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial-VIP Report No. 1 Ophthalmology 108 841 852 10.1016/S0161-6420(01)00544-9 (Pubitemid 32374237)
4. I Krebs S Binder U Stolba C Glittenberg W Brannath A Goll 2005 Choroidal neovascularization in pathologic myopia: three-year results after photodynamic therapy Am J Ophthalmol 140 416 425 16139000 10.1016/j.ajo.2005.03.050 (Pubitemid 41224831)
5. A Pece V Isola M Vadala D Matranga 2006 Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization secondary to pathologic myopia Retina 26 746 751 16963846 10.1097/01.iae.0000244256.60524.c0 (Pubitemid 44386095)
6. UEK Schnurrbusch C Jochmann P Wiedemann S Wolf 2005 Quantitative assessment of the long-term effect of photodynamic therapy in patients with pathologic myopia Graefes Arch Clin Exp Ophthalmol 243 829 833 16133036 10.1007/s00417-005-1147-4 (Pubitemid 41300427)
7. N Okamoto T Tobe SF Hackett H Ozaki MA Vinores W LaRochelle DJ Zack PA Campochiaro 1997 Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization Am J Pathol 151 281 291 9212753 1:CAS:528:DyaK2sXkslartb8%3D
8. VIP Study Group 2003 Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial-VIP Report No. 3 Ophthalmology 110 667 673 10.1016/S0161-6420(02)01998-X (Pubitemid 36520061)
9. K Hayashi K Ohno-Matsui S Teramukai N Shimada M Moriyama W Hara T Yoshida T Tokoro M Mochizuki 2008 Photodynamic therapy with verteporfin for choroidal neovascularization of pathologic myopia in Japanese patients: comparison with nontreated controls Am J Ophthalmol 145 3 518 526 18207125 10.1016/j.ajo.2007. 10.032 1:CAS:528:DC%2BD1cXitVWqs7w%3D
10. Y Ikuno Y Nagai S Matsuda A Arisawa K Sho T Oshita K Takahashi Y Uchihori F Gomi 2010 Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularization Am J Ophthalmol 149 1 140 146 19846061 10.1016/j.ajo.2009.08.008
11. JA Montero JM Ruiz-Moreno 2003 Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation Br J Ophthalmol 87 173 176 12543746 10.1136/bjo.87.2.173 1:STN:280:DC%2BD3s%2FjsFyktg%3D%3D (Pubitemid 36152743)
12. M Gharbiya F Allievi L Mazzeo CB Gabrieli 2009 Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results Am J Ophthalmol 147 84 93 18774547 10.1016/j.ajo.2008.07.022 1:CAS:528:DC%2BD1cXhsFajs7nK e1
13. K Hayashi K Ohno-Matsui S Teramukai N Shimada M Moriyama W Hayashi T Yoshida T Tokoro M Mochizuki 2009 Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy Am J Ophthalmol 148 396 408 19427991 10.1016/j.ajo.2009.03.026 1:CAS:528:DC%2BD1MXhtVaqsb7J
14. Y Ikuno K Sayanagi K Soga M Sawa M Tsujikawa F Gomi Y Tano 2009 Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results Am J Ophthalmol 147 94 100 18774550 10.1016/j.ajo.2008.07.017 1:CAS:528:DC%2BD1cXhsFajs7nL e1
15. WM Chan TY Lai DT Liu DS Lam 2009 Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study Br J Ophthalmol 93 150 154 18801766 10.1136/bjo.2008.145797
16. O Ouhadj A Bouarfa S Akel L Mendil A Nebab MT Nouri 2010 Intravitreal ranibizumab injections for the treatment of choroidal neovascularization complicating high myopia J Fr Ophtalmol 33 649 654 21047702 10.1016/j.jfo.2010. 09.004 1:STN:280:DC%2BC3M%2FjtlajsQ%3D%3D Epub 2010 Nov 2
17. Vadalà M, Pece A, Cipolla S, Monteleone C, Fasolino G, Casuccio A, Cillino S (2010) Is ranibizumab effective in stopping the loss of vision for choroidal neovascularisation in pathologic myopia? A long-term follow-up study. Br J Ophthalmol Oct 8. [Epub ahead of print]
18. PL Cornut M Poli A Feldman H El Chehab B Swalduz C Burillon P Denis 2010 Intravitreal ranibizumab for choroidal neovascularization secondary to pathological myopia: 12-month results J Fr Ophtalmol 33 327 333 20452098 10.1016/j.jfo.2010.03.006
19. T Baba M Kubota-Taniai M Kitahashi K Okada Y Mitamura S Yamamoto 2010 Two-year comparison of photodynamic therapy and intravitreal bevacizumab for treatment of myopic choroidal neovascularization Br J Ophthalmol 94 864 870 19965833 10.1136/bjo.2009.166025
20. JU Yoon YJ Byun HJ Koh 2010 Intravitreal anti-VEGF versus photodynamic therapy with verteporfin for treatment of myopic choroidal neovascularization Retina 30 418 424 20094012 10.1097/IAE.0b013e3181bd2fe4
21. F Gomi K Nishida Y Oshima H Sakaguchi M Sawa M Tsujikawa Y Tano 2007 Intravitreal bevacizumab for idiopathic choroidal neovascularization after previous injection with posterior subtenon triamcinolone Am J Ophthalmol 143 507 509 17317397 10.1016/j.ajo.2006.10.050 1:CAS:528:DC%2BD2sXitFOktrk%3D
22. P Bhatnagar KB Freund RF Spaide JM Klancnik Jr MJ Cooney I Ho HF Fine LA Yannuzzi 2007 Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum Retina 27 897 902 17891014 10.1097/IAE.0b013e31809ff5df (Pubitemid 47479384)
23. MB Prodi S Da Pozzo G Ravalico 2007 Retinal pigment epithelium changes after photodynamic therapy for choroidal neovascularization in pathological myopia Acta Ophthalmol Scand 85 50 54 (Pubitemid 46140156)
24. ID Ladas MM Moschos AA Rouvas DA Karagiannis SN Kokolakis 2003 Lacquer crack formation after photodynamic therapy Eur J Ophthalmol 13 729 733 14620181 1:STN:280:DC%2BD3srjvVyitw%3D%3D (Pubitemid 37409135)
25. K Ohno-Matsui M Moriyama K Hayashi M Mochizuki 2006 Choroidal vein and artery occlusion following photodynamic therapy in eyes with pathologic myopia Graefes Arch Clin Exp Ophthalmol 244 1363 1366 16523294 10.1007/s00417-006-0303- 9 (Pubitemid 44463481)
26. DSC Lam WM Chan DTL Liu DS Fan WW Lai KK Chong 2004 Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow-up Br J Ophthalmol 88 1315 1319 15377558 10.1136/bjo.2004.041624 1:STN:280:DC%2BD2cvms12luw%3D%3D (Pubitemid 39312979)